Form 4 for EW Edwards Lifesciences
Accepted 2022-05-17 00:00:00 ET · period of report 2022-05-17 · accession 0001225208-22-007138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-17 | 2022-05-17 | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $95.93 | -1,730 | 33.3K | -5% | -$166.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | F | D | 1,730 | $95.93 | 33,303.66 | D | — | — |